Scientists test new leukemia Pill's heart safety on healthy people
Knowledge-focused
Recruiting now
This is an early safety study to see if a potential new drug for a type of leukemia (AML with FLT3 mutation) affects the heart's electrical rhythm. It will involve 45 to 75 healthy Chinese volunteers who will take a single dose of the drug, a placebo, or a comparison drug. Resear…
Phase: PHASE1 • Sponsor: Shijiazhuang Yiling Pharmaceutical Co. Ltd • Aim: Knowledge-focused
Last updated Mar 12, 2026 13:50 UTC